OPEN END TURBO OPTIONSSCHEIN LONG - QUEST DIAGNOSTICS | Real-time BOERSE MUENCHEN 06:25:49 2024-06-20 EDT | ||
| 10.65 EUR | +0.09% |
|
| Current month | -1.75% | ||
| 1 month | -3.71% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
More news
| Date | Price | Change |
|---|---|---|
| 24-06-20 | 10.65 | +0.09% |
| 24-06-19 | 10.64 | -0.09% |
| 24-06-18 | 10.65 | -0.09% |
| 24-06-17 | 10.66 | -1.11% |
| 24-06-14 | 10.78 | +0.47% |
Real-time BOERSE MUENCHEN
Last update June 20, 2024 at 06:25 am
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | Goldman Sachs |
| WKN | GK5JDZ |
| ISIN | DE000GK5JDZ0 |
| Date issued | 2022-05-25 |
| Strike | 23.81 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 10.94 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 12.83 € |
|---|---|
| Lowest since issue | 9.27 € |
| Spread | 0.05 € |
| Spread % | 0.47% |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
137.3
USD
Average target price
147
USD
Spread / Average Target
+7.06%
- Stock Market
- Certificates
- Certificat
